ARCHIVES

Marijuana-Derived Drug Less Effective Than Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

Patients Prefer Silicone Over Saline Implants

November 26, 2010

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

White House Budget asks $1.101 Billion For NCI In FY 1985; R01-P01 Pool Goes Up By 5.5 Percent

February 10, 1984

Tighter Payment Policy

November 5, 2010

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988